Home › Funds › Point72 Asset Management › ARWR
Point72 Asset Management position in ARWR
ARROWHEAD PHARMACEUTICALS IN · Health Care
Latest position (Q2 2026)15.40K sh
Reported value held$1.26M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 160.50K | $10.02M | New |
| Q4 2021 | 44.29K | $2.94M | Reduce |
| Q1 2022 | 561.10K | $25.80M | Add |
| Q2 2022 | 395.87K | $13.94M | Reduce |
| Q3 2022 | 666.60K | $22.03M | Add |
| Q4 2022 | 56.65K | $2.30M | Reduce |
| Q2 2023 | 908 | $32.38K | New |
| Q3 2023 | 811 | $21.79K | Reduce |
| Q4 2025 | 31.90K | $2.12M | New |
| Q1 2026 | 46.40K | $2.91M | Add |
| Q2 2026 | 15.40K | $1.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ARWR
- BlackRock Inc 14.83M sh · $1.21B · Q2 2026
- Vanguard Group 15.29M sh · $1.02B · Q4 2025
- Norges Bank Investment Management 3.90M sh · $317.61M · Q2 2026
- Geode Capital Management 3.53M sh · $298.81M · Q2 2026
- Northern Trust Corp 1.19M sh · $97.23M · Q2 2026
- Goldman Sachs Group 1.15M sh · $93.74M · Q2 2026
- Janus Henderson Group 1.44M sh · $90.12M · Q1 2026
- Charles Schwab Investment Management 923.93K sh · $75.31M · Q2 2026
- BNY Mellon 859.54K sh · $70.06M · Q2 2026
- JPMorgan Chase & Co 637.40K sh · $51.77M · Q2 2026
- Two Sigma Investments 580.61K sh · $47.33M · Q2 2026
- Principal Global Investors 514.66K sh · $41.95M · Q2 2026